| Primary |
| Huntington's Disease |
37.7% |
| Huntington's Chorea |
16.4% |
| Product Used For Unknown Indication |
9.8% |
| Dyskinesia |
7.6% |
| Tardive Dyskinesia |
7.2% |
| Chorea |
4.9% |
| Dystonia |
3.9% |
| Tourette's Disorder |
3.4% |
| Drug Use For Unknown Indication |
3.3% |
| Tic |
1.2% |
| Tremor |
1.0% |
| Torticollis |
0.8% |
| Movement Disorder |
0.7% |
| Meige's Syndrome |
0.6% |
| Extrapyramidal Disorder |
0.3% |
| Muscle Spasms |
0.3% |
| Parkinsonism |
0.3% |
| Anxiety |
0.2% |
| Choreoathetosis |
0.2% |
| Depression |
0.2% |
|
| Death |
50.7% |
| Suicidal Ideation |
7.2% |
| Somnolence |
5.6% |
| Tremor |
4.2% |
| Depression |
3.9% |
| Vomiting |
3.5% |
| Weight Decreased |
2.7% |
| Insomnia |
2.6% |
| Pneumonia |
2.5% |
| Suicide Attempt |
1.9% |
| Fatigue |
1.8% |
| Product Quality Issue |
1.8% |
| Hospitalisation |
1.7% |
| Restlessness |
1.7% |
| Tardive Dyskinesia |
1.5% |
| Dysphagia |
1.4% |
| Dyspnoea |
1.4% |
| Condition Aggravated |
1.3% |
| Huntington's Disease |
1.3% |
| Muscle Spasms |
1.3% |
|
| Secondary |
| Product Used For Unknown Indication |
24.0% |
| Dyskinesia |
11.5% |
| Drug Use For Unknown Indication |
10.6% |
| Huntington's Disease |
6.7% |
| Tardive Dyskinesia |
6.7% |
| Phlebitis |
5.8% |
| Acne |
3.8% |
| Insomnia |
3.8% |
| Irritability |
3.8% |
| Parkinsonism |
3.8% |
| Anxiety |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Affect Lability |
1.9% |
| Chorea |
1.9% |
| Major Depression |
1.9% |
| Movement Disorder |
1.9% |
| Orofacial Dyskinesia |
1.9% |
| Parkinsonian Rest Tremor |
1.9% |
| Abnormal Behaviour |
1.0% |
| Affective Disorder |
1.0% |
|
| Lipase Increased |
10.0% |
| Suicidal Ideation |
10.0% |
| Claustrophobia |
6.7% |
| Electrocardiogram Qt Prolonged |
6.7% |
| Lip Dry |
6.7% |
| Sedation |
6.7% |
| Sudden Death |
6.7% |
| Tinnitus |
6.7% |
| Activities Of Daily Living Impaired |
3.3% |
| Anxiety |
3.3% |
| Cardiomyopathy |
3.3% |
| Cognitive Disorder |
3.3% |
| Confusional State |
3.3% |
| Convulsion |
3.3% |
| Dyspnoea |
3.3% |
| Hyperkinesia |
3.3% |
| Knee Arthroplasty |
3.3% |
| Nausea |
3.3% |
| Palpitations |
3.3% |
| Parkinsonian Gait |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.8% |
| Dyskinesia |
12.5% |
| Pain |
8.3% |
| Hypertension |
6.3% |
| Impaired Gastric Emptying |
5.2% |
| Multiple Sclerosis |
5.2% |
| Rheumatoid Arthritis |
5.2% |
| Depression |
4.2% |
| Tourette's Disorder |
4.2% |
| Blood Cholesterol Increased |
3.1% |
| Huntington's Disease |
3.1% |
| Insomnia |
3.1% |
| Narcolepsy |
3.1% |
| Pyrexia |
3.1% |
| Tardive Dyskinesia |
3.1% |
| Akathisia |
2.1% |
| Fibromyalgia |
2.1% |
| Grand Mal Convulsion |
2.1% |
| Sleep Disorder |
2.1% |
| Affective Disorder |
1.0% |
|
| Product Substitution Issue |
12.0% |
| Cognitive Disorder |
8.0% |
| Tardive Dyskinesia |
8.0% |
| Tremor |
8.0% |
| Blood Glucose Increased |
4.0% |
| Cystitis |
4.0% |
| Device Failure |
4.0% |
| Drug Effect Decreased |
4.0% |
| Drug Ineffective |
4.0% |
| Erectile Dysfunction |
4.0% |
| Gait Disturbance |
4.0% |
| Headache |
4.0% |
| Impaired Gastric Emptying |
4.0% |
| Injection Site Haematoma |
4.0% |
| Leukaemia |
4.0% |
| Lung Adenocarcinoma |
4.0% |
| Muscular Weakness |
4.0% |
| Parkinsonism |
4.0% |
| Rash Morbilliform |
4.0% |
| Reticulocyte Count Decreased |
4.0% |
|
| Interacting |
| Huntington's Disease |
40.0% |
| Abnormal Behaviour |
20.0% |
| Conduct Disorder |
20.0% |
| Micturition Disorder |
20.0% |
|
| Electrocardiogram Qt Prolonged |
66.7% |
| Tic |
33.3% |
|
